Patents by Inventor Michelle Rowney
Michelle Rowney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10456453Abstract: The invention provides a method of treating a disorder characterised by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided.Type: GrantFiled: September 13, 2017Date of Patent: October 29, 2019Assignees: AGRICULTURE VICTORIA SERVICES PTY LTD, SAPUTO DAIRY AUSTRALIA PTY LIMITEDInventors: Matthew McDonagh, Benjamin Cocks, Angus Tester, Peter Hobman, Andrew Brown, Michelle Rowney
-
Publication number: 20180000908Abstract: The invention provides a method of treating a disorder characterised by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided.Type: ApplicationFiled: September 13, 2017Publication date: January 4, 2018Inventors: Matthew MCDONAGH, Benjamin COCKS, Angus TESTER, Peter HOBMAN, Andrew BROWN, Michelle ROWNEY
-
Patent number: 9789168Abstract: The invention provides a method of treating a disorder characterized by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided.Type: GrantFiled: July 28, 2015Date of Patent: October 17, 2017Assignees: AGRICULTURE VICTORIA SERVICES PTY LTD, Murray Goulburn Co-Operative Co., LimitedInventors: Matthew McDonagh, Benjamin Cocks, Angus Tester, Peter Hobman, Andrew Brown, Michelle Rowney
-
Patent number: 9662368Abstract: The present invention relates to a formulation comprising whey protein or a hydrolysate of whey protein, which formulation is capable of inhibiting the expression of TNF? in lipopolysaccharide-stimulated macrophages in vitro. Also provided are uses of the formulation for attenuating a reduction in muscle function which results from muscle damage and/or for enhancing recovery from muscle damage and/or for enhancing the force generating capacity of muscle and methods of making the formulation.Type: GrantFiled: June 15, 2007Date of Patent: May 30, 2017Assignee: MURRAY GOULBURN CO-OPERATIVE., LIMITEDInventors: Michelle Rowney, Andrew Brown, Yu Pan, Jonathan David Buckley
-
Patent number: 9480717Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.Type: GrantFiled: September 4, 2012Date of Patent: November 1, 2016Assignee: Murray Goulburn Co-Operative Co LimitedInventors: Michelle Rowney, David Cameron-Smith
-
Patent number: 8551547Abstract: The invention provides a process for the preparation of an angiogenin-enriched fraction from a milk product, the process comprising contacting the milk product with a cation exchange resin and eluting the angiogenin-enriched fraction from the cation exchange resin with a mobile phase. The invention also provides angiogenin-enriched fractions produced by process and food products, nutraceuticals and pharmaceutical comprising such angiogenin.Type: GrantFiled: November 9, 2007Date of Patent: October 8, 2013Assignees: Murray Goulburn Co-operative Co., Limited, Agriculture Victoria Services Pty Ltd.Inventors: Andrew Brown, Michelle Rowney, Peter Hobman, Matthew McDonagh, Angus Tester, Benjamin Cocks
-
Publication number: 20130236508Abstract: The method relates to a method of treating proteinuria comprising administering lactoferrin.Type: ApplicationFiled: June 24, 2011Publication date: September 12, 2013Applicant: MURRAY GOULBURN CO-OPERATIVE CO. LIMITEDInventors: Peter Hobman, Kerrie Sanders, Michelle Rowney, Geoff Nicholson
-
Publication number: 20130195990Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.Type: ApplicationFiled: September 4, 2012Publication date: August 1, 2013Applicant: MURRAY GOULBURN CO-OPERATIVE CO LIMITEDInventors: Michelle ROWNEY, David CAMERON-SMITH
-
Publication number: 20130078313Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as methods for supplementing the nutritional needs of individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to increase skeletal muscle strength.Type: ApplicationFiled: May 24, 2012Publication date: March 28, 2013Applicant: MURRAY GOULBURN CO-OPERATIVE CO LIMITEDInventors: Michelle ROWNEY, David CAMERON-SMITH, Scott CONNELLY
-
Patent number: 8282927Abstract: The invention relates to the production of compositions containing IgA for use as a food additive. More specifically, it relates to a process to prepare an IgA-enriched milk product extract composition and to such compositions.Type: GrantFiled: May 10, 2006Date of Patent: October 9, 2012Assignee: Murray Goulburn Co-Operative Co LimitedInventors: Andrew Brown, Peter Hobman, Richard Paine, Michelle Rowney
-
Publication number: 20110098254Abstract: The present invention provides compositions comprising phospholipids and particularly those comprising at least 40% phospholipid and at least 80% phospholipid as a percentage of total fat in the extract, comprising polyunsaturated and saturated phospholipids, in a ratio of saturated phospholipid to monounsaturated to polyunsaturated phospholipid of about 6:3:1 respectively, or comprising at least 40% phospholipid and less than 40% protein and methods for their production from dairy products.Type: ApplicationFiled: August 15, 2008Publication date: April 28, 2011Inventors: Andrew Brown, Michelle Rowney
-
Publication number: 20100136172Abstract: The invention provides a process for the preparation of an angiogenin-enriched fraction from a milk product, the process comprising contacting the milk product with a cation exchange resin and eluting the angiogenin-enriched fraction from the cation exchange resin with a mobile phase. The invention also provides angiogenin-enriched fractions produced by process and food products, neutraceuticals and pharmaceutical comprising such angiogenin.Type: ApplicationFiled: November 9, 2007Publication date: June 3, 2010Inventors: Andrew Brown, Michelle Rowney, Peter Hobman, Matthew McDonagh, Angus Tester, Benjamin Cocks
-
Publication number: 20090324733Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.Type: ApplicationFiled: September 8, 2006Publication date: December 31, 2009Applicant: Murray Goulburn Co-Opeartive Co LimitedInventors: Michelle Rowney, David Cameron-Smith
-
Publication number: 20090298767Abstract: The present invention relates to a formulation comprising whey protein or a hydrolysate of whey protein, which formulation is capable of inhibiting the expression of TNF? in lipopolysaccharide-stimulated macrophages in vitro. Also provided are uses of the formulation for attenuating a reduction in muscle function which results from muscle damage and/or for enhancing recovery from muscle damage and/or for enhancing the force generating capacity of muscle and methods of making the formulation.Type: ApplicationFiled: June 15, 2007Publication date: December 3, 2009Inventors: Michelle Rowney, Andrew Brown, Yu Pan, Jonathan David Buckley
-
Publication number: 20090214567Abstract: The invention relates to the production of compositions containing IgA for use as a food additive. More specifically, it relates to a process to prepare an IgA-enriched milk product extract composition and to such compositions.Type: ApplicationFiled: May 10, 2006Publication date: August 27, 2009Applicant: MURRAY GOULBURN CO-OPERATIVE CO LIMITEDInventors: Andrew Brown, Peter Hobman, Richard Paine, Michelle Rowney
-
Publication number: 20090169675Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as methods for supplementing the nutritional needs of individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to increase skeletal muscle strength.Type: ApplicationFiled: September 8, 2006Publication date: July 2, 2009Applicant: Murray Goulburn Co-Opeartive Co LimitedInventors: Michelle Rowney, David Cameron-Smith, Scott Connelly
-
Publication number: 20080293159Abstract: The present invention provides a process for validating the efficacy of a sample having a known activity determined using a biological assay. The process includes subjecting the sample to a biological assay capable of testing for the activity. The process may optionally include an initial step of determining a biological assay for the desired activity. The present invention is particularly applicable to samples from milk.Type: ApplicationFiled: July 24, 2007Publication date: November 27, 2008Inventors: Michelle Rowney, Peter Hobman, Stewart Davey